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ABSTRACT
The non-natural pyrido[2,3-d]pyrimidine nucleoside F,
which pairs preferentially with guanine (G) and adenine
(A) within double-helical DNA, recognizes with high
selectivity AT base pairs within triple-helical
complexes. These observations suggest that F may
exist in different tautomeric forms within double-helical
and triple-helical complexes. Analysis of the base
stacking properties of this extended ring system using
two oligodeoxyribonucleotides containing terminal
thymines and/or pyrido[2,3-rf]pyrimidines bound to
adjacent sites showed a decrease in free energy of
binding in a triple-helical complex in the order (5' - 3')
TT > FT > TF > FF.
INTRODUCTION
Oligonucleotide-directed formation of local triple-helical
structures may serve as a powerful method to target single sites
within large sequences of double-helical DNA (1,2). There are
two major triple-helical structures through which oligodeoxyribo-
nucleotides bind purine tracts in the major groove of double-
helical DNA. Pyrimidine-rich oligodeoxyribonucleotides bind
parallel to the Watson-Crick purine strand through formation
of Hoogsteen hydrogen bonds between thymine (T) and
adenine—thy mine (AT) base pairs (T-AT) and between
protonated cytosine (C+) and guanine—cytosine (GC) base pairs
(C+GC) (1—4), whereas purine-rich oligodeoxyribonucleotides
bind antiparallel to the Watson-Crick purine strand through
reverse Hoogsteen hydrogen bond formation between G and GC
base pairs and A or T and AT base pairs (5 — 8). The discovery
of other natural and non-natural base triplets (9-18) and the use
of alternate strand triple-helix formation (19—23) has increased
the number of double-helical sequences that can be recognized
beyond simple purine tracts. However, a general solution for
specific recognition of all four natural bases through triple-helix
formation has still not been achieved. The design criteria for
heterocycles that can selectively recognize double-helical DNA
include (i) appropriate positioning of hydrogen bond donors and
acceptors for pairing with the edges of AT and GC Watson-
Crick base pairs, (ii) a non-disruptive backbone geometry of the
novel nucleotide, and (iii) optimal base stacking within the third
strand.
It has previously been reported that the non-natural
pyrido[2,3-rf]pyrimidine nucleoside F pairs with G and A within
double-helical DNA (24). One explanation is that a single
tautomeric form of F forms a Watson-Crick base pair with G
and, through a backbone shift, a wobble base pair with A (24).
An alternative explanation is that F exists in different tautomeric
forms Fj and F2, whose equilibrium is influenced by the base
in the opposing DNA strand (Figure la). The heterocycle F is
structurally related to the natural pyrimidine bases and should
therefore be able to maintain a correct backbone geometry within
the pyrimidine—purine-pyrimidine triple-helix. Tautomer F!
carrying the proton at N-8 resembles a C base analog, which
may allow recognition of GC and/or CG base pairs within the
pyrimidine triple-helical motif (Figures 2, 3a). Tautomer F2
carrying the proton at N-l corresponds to a T analog, which
should recognize AT base pairs within a triple-helical complex
(Figures 2, 3b). The following report presents experiments
designed to identify the base specificity and binding affinity of
the non-natural pyrido[2,3-<flpyrimidine nucleoside F within
triple-helical complexes.
MATERIALS AND METHODS
General
The 5-methyl-2'-deoxycytidine (dC) phosphoramidite was
purchased from Glen Research. All other phosphoramidites and
chemicals for DNA synthesis were obtained from Applied
Biosystems Inc. All enzymes were purchased from Boehringer-
Mannheim, New England Biolabs or Sigma. Restriction
endonucleases were used according to the supplier's
recommended protocol in the activity buffer provided. The
Sequenase™ DNA sequencing kit (Version 2.0) was obtained
from United States Biochemical Inc. Deoxynucleoside
triphosphates (100 mM solutions), calf thymus DNA, NICK™-
columns and NAP-5 Sephadex columns were purchased from
Pharmacia LKB. Glycogen was obtained from Boehringer-
Mannheim as a 20 mg/ml aqueous solution. The radiolabeled
triphosphates [a-32P]dGTP (> 3000 Ci/mmol), [7-32P]ATP (>
5000 Ci/mmol) and [a-35S]dATP (> 1000 Ci/mmol) were
obtained from Amersham. All other chemicals were of analytical
or HPLC grade. Standard molecular biological methods were
used, if not mentioned otherwise (25, 26). Thermal denaturation
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Figure 1. Possible hydrogen bond formation between pyrido[2,3-d]pyrimidine F and the natural bases G and A. F, and F2 refer to different possible tautomers.
profiles were obtained on a Hewlett-Packard 8452A diode array
spectrophotometer.
Synthesis of oligodeoxyribonucleotides
Oligodeoxyribonucleotides were synthesized on an Applied
Biosystems Model 380B DNA synthesizer using standard solid-
phase /3-cyanoethyl phosphoramidite chemistry (26, 27). The
pyridopyrimidine heterocycle F was prepared as previously
reported in the literature (28) and incorporated either within or
at the 5'-end of an oligodeoxyribonucleotide during a regular
cycle or at the 3'-end of an oligodeoxyribonucleotide via the 5'-O-
DMT—thymidine - EDTA - triethylester-3' -succiny 1 controlled
pore glass (29). The thymidine-EDTA nucleoside analog T*
was prepared according to published procedures and incorporated
at the 5' end (30). Unmodified oligodeoxyribonucleotides were
deprotected in concentrated ammonium hydroxide at 55 °C for
24 hours. Oligodeoxyribonucleotides containing the nucleoside
analog T* were treated with 0.1 N NaOH (1.5 ml) at 55°C for
24 hours and the resulting solutions were neutralized with glacial
acetic acid. The resulting mixture was applied to a column of
Sephadex G10-120 and eluted with water. The crude
oligodeoxyribonucleotides were lyophilized and then purified by
electrophoresis on 20% denaturing poly aery lamide gels (19:1
monomer/bis). The major UV-absorbing bands were excised,
crushed and eluted (0.5 M NaCl, 0.5 XTE, 37°C, 36 h). After
filtration through a Centrex filter (0.45 /xm) the oligodeoxyribo-
nucleotides were desalted on Pharmacia NAP-5 Sephadex
columns and then exhaustively dialyzed against water. The
concentrations of the oligodeoxyribonucleotides were determined
by UV measurements at 260 nm on a Hewlett-Packard 8452A
diode array spectrophotometer, using the following molar
extinction coefficients: 15400 (dA), 11700 (dG), 5700 (dC), 8800
(T and T*), and 15000 (F) cm"1 M"1. The oligodeoxyribo-
nucleotide solutions were then divided in aliquots, lyophilized
to dryness, and stored at - 7 8 °C.
HPLC analyses
Analytical HPLC was performed with a Hewlett-Packard 1090
Liquid Chromatograph using a reverse phase VYDAC 201HS54
4.6 mmx25 cm 5 micron C18 column. The purified
oligodeoxyribonucleotides (3 nmol) were digested simultaneously
with snake venom phosphodiesterase (3 fd, 2.4 /tg//tl) and calf
intestine alkaline phosphatase (3 jtl, 1 U/jtl) in 50 mM Tris-HCl
(pH 8.1), 100 mM MgCl2. The reaction mixture was incubated
at 37°C for 3h, filtered through a 0.45 /im Nylon-66 syringe
filter (Rainin) and lyophilized. The sample was dissolved in 10
/il water, and an aliquot of the solution was injected onto the
C18 reverse phase column. The products were eluted with 20
mM triethylammonium acetate and 1 mM EDTA with a gradient
Figure 2. Tautomeric forms of F.
of 2.5—50% acetonitrile and detected by UV absorption at 260
and 330 nm. Comparison with standard solutions of dA, dG,
dC, T and dF confirmed the composition of the
oligodeoxyribonucleotides.
DNA manipulations
Plasmid DNA (pPG1133 or pMD5152) was linearized with
EcoRl, followed by treatment with [a-32P]dATP and
[a-32P]TTP in the presence of Sequenase™ (version 2.0).
Unincorporated radiolabeled nucleotide triphosphates were
removed by fltration of the reaction mixture through a NICK™-
column. The labeled DNA was precipitated and digested with
PvuU in the case of pPGl 133 or Ndel in the case of pMD5152.
The resulting 3'-32P-end labeled fragments were purified by 5%
nondenaturing polyacrylamide gel electrophoresis. Gel bands
were visualized by autoradiography, excised and crushed, and
eluted with 250 mM NaCl, 10 mM Tris, pH 8.0 at 37°C for
24 h. The resulting mixture was filtered through a 0.45 /xm
Centrex filter, and the eluted DNA was ethanol precipitated and
dried in vacuo. The pellet was resuspended in TE buffer (10 mM
Tris, pH 8.0, 1 mM EDTA), extracted 3 - 5 times with phenol,
and twice with 24:1 chloroform/isoamyl alcohol, and ethanol
precipitated. The DNA pellet was washed with 70% ethanol,
dried in vacuo, and resuspended in 25 mM Tris—acetate, 100
mM NaCl, pH 7.0 and stored at -78°C.
Quantitative affinity cleavage titrations
In a typical quantitative affinity cleavage titration experiment,
involving eighteen data lanes and one control lane per gel, a stock
solution containing labeled target DNA in association buffer was
prepared by mixing 50 mM Bis-Tris-HCl buffer at pH 7.0, 500
mM NaCl, 1.25 mM spermine hydrochloride, calf thymus DNA
at a concentration of 2.0 mM in base pairs, approximately
400,000 cpm of 3'-end labeled target DNA, and enough water
to bring to a total volume of 665 /*1. The stock solution was then
distributed among nineteen 1.5 ml microcentrifuge tubes in 35
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Figure 3. Two dimensional models of base triplets containing either (a)
(b) F2 opposite all four Watson-Crick base pairs.
/il aliquots. A dried pellet of the oligodeoxyribo-
nucleotide-EDTA (5 nmol) was dissolved in aqueous solution
to produce a 100 /iM solution of oligodeoxyribonucleotide and
was diluted serially. To each reaction tube was added 5 \A of
oligodeoxyribonucleotide at the appropriate concentration and 5
/tl of a 75 /tM solution of Fe(NH4)2(SO4)2-36H2O. The oligo-
deoxyribonucleotide-EDTA • Fe(II) and the DNA were allowed
to equilibrate for 24 h at 24°C. The cleavage reactions were
initiated by the addition of 5 \A of a 40 mM DTT solution to
each tube. The reactions were incubated for 6 h at 24°C. Final
reaction conditions for the affinity cleaving reactions to determine
base specificity in 50 /tl association buffer were 10 mM Bis-
Tris-HCl at pH 7.0, 100 mM NaCl, 0.25 mM spermine, 0.1
mM base pairs calf thymus DNA, 4 mM DTT, and
approximately 21,000 cpm labeled duplex. Final reaction
conditions for the affinity cleaving reactions to determine
cooperative interactions in 50 /tl association buffer were 25 mM
Tris-acetate at pH 7.0, 10 mM NaCl, 1 mM spermine, 0.1 mM
base pairs calf thymus DNA, 4 mM DTT, and approximately
21,000 cpm labeled duplex. The cleavage reactions were
quenched by the addition of glycogen to a final concentration
of 70 /tg/ml, NaOAc to a final concentration of 280 mM (pH
5.2), and MgCl2 to a final concentration of 10 mM, The DNA
was precipitated with 2.5 volumes cold ethanol, isolated by
centrifugation and subsequently dissolved in 20 /tl distilled water.
The solutions were frozen and the solvent was removed by
lyophilization. The DNA in each tube was resuspended in 5 /*1
formamide-TBE loading buffer, and the solutions were
Figure 4. Qualitative analysis comparing the relative stabilities of the 16 natural
base triplets with the four nonnatural base triplets F-AT, F-GC, F-CG, and FTA.
(A) Sequences of oligonucleotide-EDTA 1 - 5; (B) Schematic drawing of the triple-
helix complex between the bound oligonucleotide-EDTA • Fe(II) and a single site
containing all four base pairs (X-Y); (C) Autoradiogram of a 8% denaturing
polyacrylamide gel: the cleavage reactions containing the oligonucleotide-EDTA
(1 iM) and Fe(II) (25 /»m) with the 32p labeled restriction fragment in association
buffer (50 mM Tris-acetate, pH 7.0,100 mM NaCl, 1 mM spermine, 100 /tM
bp calf thymus DNA) were allowed to equilibrate at room temperature for 24 h.
The cleavage reactions were initiated by addition of DTT (4 mM) and allowed
to proceed for 6 h at room temperature. The reactions were stopped by precipitation
with ethanol and the cleavage products were analyzed by gel electrophoresis.
Lane 1: control showing intact restriction fragment; lane 2: products of chemical
sequencing reaction; lane 3 — 18: DNA cleavage products produced by
oligonucleotide-EDTA Fe(II) [Z=A (lanes 3-6) , Z=G (lanes 7-10), Z=MeC
lanes (11-14), Z=T (lanes 15-18), Z = F (lanes 19-22)].
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Figure 5. Autoradiogram of an 8% denaturing polyacrylamide gel of reaction
products from affinity cleavage reactions with oligonucleotide 5 (Z=F) and a
P-labeled restriction fragment containing the target site shown in Figure 4
where XY=AT. The reactions were performed at 24°C in 10 mM Bis-Tris. HC1
pH 7.0, 100 mM Na+, 250 fM spermine tetrahydrochloride. 100 iM bp calf
thymus DNA. Lane 1: products of chemical sequencing reaction; lanes 2 — 19:
DNA affinity cleavage reaction products produced by 5 at various concentrations:
10 nM (lane 2); 8 pM (lane 3); 4>iM Cane 4); 2 ^M (lane 5); ljtM (lane 6);
800 nM (lane 7); 400 nM (lane 8); 200 nM (lane 9); 100 nM (lane 10); 80 nM
(lane 11); 40 nM (lane 12); 20 nM (lane 13); 10 nM (lane 14); 8 nM (lane 15);
4 nM (lane 16); 2 nM (lane 17); 1 nM (lane 18); no oligonucleotide (lane 19).
transferred to new tubes, assayed for specific activity by
scintillation counting, and if necessary diluted to 3000-4000
cpm//il with more formamide—TBE loading buffer. The DNA
was denatured at 90°C for 5 min and 5 /tl of each sample were
loaded onto an 8% denaturing polyacrylamide gel (19:1;
monomer/bis).
Affinity cleaving titration fitting procedure
Gels were exposed to photostimulable storage phosphor imaging
plates (Kodak Storage Phosphor Screen S0230 from Molecular
Dynamics) at room temperature for 12—24 h. The data was
transferred from the phosphor imaging screens to a Molecular
Dynamics 400S Phosphorlmager. Rectangles of identical
dimensions were drawn around the cleavage bands at the target
and the reference sites. The ImageQuant v.3.0 program running
1.2
10" 10°
[Oligo'Fe] (mol'L1)
10"
Figure 6. Data for quantitative affinity cleavage titration experiments from triple-
helical complexes of oligodeoxyribonucleotide 5 containing the base analog F
against all four Watson-Crick base pairs AT ( • ) , CG ( • ) , GC (O) and TA ( • ) .
Table 1. Equilibrium association constants for either 15 mer 4 (Z=T) or 5 (Z=F)
binding by triple-helix formation
Watson-Crick
base pair
AT
GC
CG
TA
KTIM-1,.
Z = T
5.0 (±0.4) x 107
1.3 (±0.6) x 105
1.4 (±0.1) x 106
<105
Z = F
2.4 (±0.6) x 107
2.1 (±0.1) x 105
4.0 (±1.4) x 105
<105
° Values reported in the table are mean values measured from affinity cleavage
titration experiments performed in association buffer (10 mM Bis-Tris.HC1 pH
7.0, 100 mM Na+, 250 jtM spermine tetrahydrochloride, 100 ^ M bp calf thymus
DNA, 24°C)
on an AST Premium 386/33 computer was used to integrate the
volume of each rectangle.
The affinity cleavage titration fitting procedure has been
adapted from Singleton and Dervan (31, 32). The relative
cleavage efficiencies at the target site for each oligodeoxyribo-
nucleotide concentration were determined by using the following
equation:
where /site and /ref are the intensities of the cleavage bands at the
target and the reference site, respectively, and X is a scaling
parameter defined as the ratio I,ol/lKf at the lowest oligodeoxy-
ribonucleotide concentration. A theoretical binding curve,
represented by eq.7 where / ^ is the apparent maximum
cleavage, Kt the equilibrium association constant for
oligonucleotide /, and [O]tot the oligodeoxyribo-
nucleotide—EDT A concentration, was used to fit the
experimental data using 4,, and Kt as adjustable parameters:
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Figure 7. Schematic representation of a triple-helical complex containing two
oligodeoxyribonucleotides bound at adjacent sites on double-helical DNA. Thick
solid lines represent the DNA backbone and the associated oligodeoxyribo-
nucleotides, thin solid or dashed lines indicate Watson-Crick or Hoogsteen
hydrogen bonds.
'fit = /sa [O]t o t /1 + AT, (7)
Minimization of the difference between /flt and /site for all data
points was performed using Kaleidagraph software. All values
reported are the means of 3 - 6 experimental observations.
RESULTS AND DISCUSSION
Analysis of base specificity for triple helix formation
Five 15 mer oligodeoxyribonucleotides (Figure 4 ,1 -5 ) that vary
at one position Z, 5'-T*TT TTC TCT ZTC TCT- 3' (Z = F,
dA, dG, dC or T), and contain the DNA-cleaving moiety
thymidine-EDTA-Fe (T*) at the 5'-end were synthesized by
standard solid phase methods (26, 27). The
pyrido[2,3-J]pyrimidine heterocycle F coupled with similar
efficiency as the commercially available dA, dC, dG, and T
phosphoramidites. The base composition of oligodeoxyribo-
nucleotide 5 containing the novel base F was established by
enzymatic degradation with snake venom phosphodiesterase and
alkaline phosphatase, followed by HPLC analysis of the
nucleoside monomers. To determine the relative affinities of the
non-natural pyrido[2,3-rf]pyrimidine heterocycle F for all four
Watson-Crick base pairs within a pyrimidine-purine-
pyrimidine triple-helix, the five 15 mer oligodeoxyribo-
nucleotides-EDTA• Fe 1-5 were allowed to equilibrate for 24 h
in association buffer (100 mM Na+, 250 /tM spermine
tetrahydrochloride, 10 mM Bis-Tris-HCl, pH 7.0, 24°C) in the
presence of the 232 bp DNA restriction fragments containing
the target sequence with one variable base pair site (Figure 4B).
The EDTA • Fe-mediated cleavage reactions were initiated by
addition of dithiothreitol (DTT) and were allowed to proceed for
6 h. Separation and analysis of the cleavage products was
performed by polyacrylamide gel electrophoresis. In addition to
the known stable triplet combinations T- AT, C+GC and GTA,
strong binding was observed for the combination Z = F, XY
= AT.
To compare the association constants for the oligodeoxyribo-
nucleotides 4 (Z = T) and 5 (Z = F) for all four Watson-Crick
base pairs, the quantitative affinity cleavage titration method was
used over an extensive concentration range using the same
Table 2. Equilibrium association constants of either 11 mer 6 (Z=T) or 7 (Z=F)
in the presence or absence of either 15 mer 8 (Z=T) or 9 (Z=F) bound to adjacent
sites on DNA within a triple helical complex.
oligo
nucleotide
6
6 + 8 (1 \M)
6 + 9 (1 uM)
7
7 + 8 (1 uM)
7 + 9 (1 uM)
KT[M-1]3
8.7 (± 2.6) x 105
1.5 (± 0.1) x 107
5.4 (± 1.0) x 106
2.2 (± 0.6) x 105
1.7 (± 0.6) x 106
7.2 (± 2.4) x 105
Enhancement
Factor
17
6
8
3
Stack
(5--31)
TT
TF
FT
FF
" Values reported in the table are mean values measured from affinity cleavage
titration experiments performed in association buffer (25 mM Tris-acetate pH
7.0, lOmM Na+, lmM spermine tetrahydrachloride, 24°C).
conditions as described above (Figures 5 and 6). The equilibrium
association constant for the triplet combination Z = F, XY =
AT was 2.4 X107 M"1 (10 mM Bis-Tris-HCl pH 7.0, 100
mM Na+, 250 fiM spermine tetrahydrochloride, 100 /xM bp calf
thymus DNA), which is comparable in energy to Z = T, XY
= AT (Figure 6, Table 1). Within a triple-helical complex F
mimics T, suggesting that the predominant tautomeric form may
be F2. Alternatively, in order to accommodate the tautomeric
form Fi, a backbone shift could occur to permit a wobble base
in the third strand.
Analysis of base stacking
Substitution of the 5-position of 2'-deoxycytidines with a methyl
group and 2'-deoxyuridines with a methyl-, ethynyl-, or
1-propynyl-group results in increased stability of triple-helical
complexes (33-37). Similar effects have recently also been
observed for two oligodeoxyribonucleotides binding adjacent
triple-helix sites, presumably due to favorable energy of base
stacking (38, 39). Quantitative affinity cleavage titration analysis
was used to determine the cooperative interactions between an
11 mer and a 15 mer oligodeoxyribonucleotide bound to adjacent
sites on DNA containing pyrido[2,3-d]pyrimidine F at the
junction (Figure 7). Two 11 mers (6 and 7) containing T* at the
5'-end and either T or F at the 3'-end as well as two 15 mers
(8 and 9) containing either T or F at the 5'-end were synthesized
by standard solid phase methods. Either 11 mer 6 or 7 equipped
with thymidine-EDTA at the 5'-position was allowed to
equilibrate with a 272 bp 3'-32P-end labeled duplex DNA
restriction fragment containing the target sequence for 24 h in
association buffer (10 mM Na+, 1 mM spermine tetrahydro-
chloride, 25 mM Tris-acetate, pH 7.0, 24°C) in the presence
or absence of either 15 mer 8 or 9 at uM concentrations sufficient
to saturate the adjacent 15 base pair target site. From affinity
cleavage titration analysis, a 17-fold increase in equilibrium
association constant was observed when oligodeoxyribonucleotide
6 bound in the presence of 8 (5'-TT-3' stack) (38). However,
binding enhancements of only 8 and 6 were observed when
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oligodeoxyribonucleotide 7 bound in the presence of 8 (5'-FT-3'
stack) and when oligodeoxyribonucleotide 6 bound in the presence
of 9 (5'-TF-3' stack). Only a 3-fold enhancement was observed
if both oligodeoxyribonucleotides contained terminal
pyrido[2,3-d]pyrimidines at the junction (7 in the presence of
9) (Table 2). These observations indicate that modification of
pyrimidine nucleosides to form extended ring systems does not
necessarily result in increased favorable base stacking
interactions.
CONCLUSION
In summary, within double-helical DNA F pairs with G > A,
whereas within a pyrimidine Hoogsteen strand of triple-helical
complexes F pairs with A. The simplest explanation of our data
is that the pyrido[2,3-fif|pyrimidine F appears to bind single and
double stranded DNA in various tautomeric forms. However,
we cannot rule out other hydrogen bonding pairing schemes
which would require backbone deformations. Clearly, direct
structural studies such as 2-D NMR will be required to confirm
the existence of different tautomers of F within double-helical
and triple-helical nucleic acids.
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